Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
09/2007
09/20/2007WO2007105620A1 Method for producing diarylethene compound and novel diarylethene compound
09/20/2007WO2007105049A1 Dibenzyl amine derivatives as cetp inhibitors
09/20/2007WO2007104933A1 Chemical compounds
09/20/2007WO2007104696A1 Antimalarial agents having polyaromatic structure
09/20/2007WO2007104560A1 Substituted 4-amino-quinazoline derivatives as regulators of metabotropic glutamate receptors and their use for producing drugs
09/20/2007WO2007104558A1 Thiazoles as nf-kb inhibitors (proteasome inhibitors)
09/20/2007WO2007104538A1 Heterobicyclic carboxamides as inhibitors for kinases
09/20/2007WO2007089768A3 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them
09/20/2007WO2007084319A3 Diaryl piperidines as cb1 modulators
09/20/2007WO2007071396A8 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions
09/20/2007WO2005030712A3 Thrombin receptor antagonists
09/20/2007WO2005019190A3 (4 -amino -1,2, 5-oxadiazol-4-yl) -hetξroaromatic compounds useful as protein kinase inhibitors
09/20/2007WO2002000649A9 Substituted quinazoline derivatives and their use as inhibitors
09/20/2007US20070219370 Process for preparing n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino] -5-thiazolecarboxamide and related metabolites thereof
09/20/2007US20070219251 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
09/20/2007US20070219249 Diarylmethylidene Piperidine Derivatives, Preparations Thereof and Uses Thereof
09/20/2007US20070219248 Salt of Oxalic Acid with -[4[2-(N-Methyl-N-(2-Pyridyl)-Amino)Ethoxy]Benzyl]Thiazolidin-2,4- Dione and a Method of its Preparation and its Use
09/20/2007US20070219235 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
09/20/2007US20070219217 Triazolone Derivatives as Mmp Inhibitors for the Treatment of Asthma and Copd
09/20/2007US20070219210 Amidopyrazole Derivative
09/20/2007US20070219197 Pyridyl alkene and pyridyl alkine- acid amides as cytostatics and immuno-suppressives
09/20/2007US20070219190 Heterocyclic NF-kB Inhibitors
09/20/2007US20070219188 Oxadiazine Derivatives
09/20/2007US20070219187 Allosteric Modulators of Metabotropic Glutamate Receptors
09/20/2007US20070219180 Muscle Relaxtion Accelerator and Therapeutic Agent for Muscular Tissue Diseases Such as Muscle Relaxation Failure
09/20/2007US20070219179 Indole Derivative Having Piperidine Ring
09/20/2007US20070218502 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation
09/20/2007CA2646516A1 Thiazoles as nf-kb inhibitors (proteasome inhibitors)
09/20/2007CA2646430A1 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
09/20/2007CA2646223A1 Novel heterocyclic nf-kb inhibitors
09/20/2007CA2645712A1 Triazole derivative or salt thereof
09/20/2007CA2645711A1 Quinolone derivative or pharmaceutically acceptable salt thereof
09/20/2007CA2644368A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
09/20/2007CA2644033A1 Heterobicyclic carboxamides as inhibitors for kinases
09/20/2007CA2644014A1 Bezothiazol derivatives as beta2 adrenoreceptor agonists
09/20/2007CA2643222A1 Substituted 4-amino-quinazoline derivatives as regulators of metabotropic glutamate receptors and their use for producing drugs
09/20/2007CA2643070A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity
09/19/2007EP1834954A1 Thiazoles as NF-kB Inhibitors (proteasome inhibitors)
09/19/2007EP1834947A2 3-substituted amino-1H-indole-2-carboxylic acid and 3-substituted amino-benzo[B]thiophene-2carboxylic acid derivatives as interleukin-4 gene expression inhibitors
09/19/2007EP1834642A2 2-thioxothiazolidin-4-one compounds and compositions as antimicrobial and antimalarial agents targeting enoyl-ACP reductase of type II fatty acid synthesis pathway and other cell growth pathways
09/19/2007EP1833827A2 Process for preparing 2-methyl-1-(2-methylpropyl)-1h-imidazoý4,5-c¨ý1,5¨naphthyridin-4-amine
09/19/2007EP1833824A1 3-cycloalkylcarbonyl indoles as cannabinoid receptor ligands
09/19/2007EP1833823A1 2,5- and 2,6-disubstituted benzazole analogues useful as protein kinase inhibitors
09/19/2007EP1833822A2 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
09/19/2007EP1833816A1 Substituted piperidines as renin inhibitors
09/19/2007EP1833802A2 1,2-diphenyl-imidazole derivatives and their use as cb1 receptor ligands
09/19/2007EP1833797A1 Azacyclic compounds as inhbitors of sensory neurone specific channels (sns)
09/19/2007EP1833792A1 Substituted piperidine compounds for use as ccr5 modulators
09/19/2007EP1740544B1 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides
09/19/2007EP1664025B1 Pyrrol derivatives with antibacterial activity
09/19/2007EP1585734A4 Anti-inflammatory medicaments
09/19/2007EP1567522B1 Pyrimidine compounds
09/19/2007EP1556388B1 A method for manufacture of ceftiofur
09/19/2007EP1480976B1 Thiazole derivatives as npy receptor antagonists
09/19/2007CN101039939A Quinazolinylmethylene thiazolinones as cdk1 inhibitors
09/19/2007CN101039935A New piperidine antibiotics
09/19/2007CN101039919A N-benzenesulfonyl substituted anilino-pyrimidine analogs
09/19/2007CN101039911A Polymorph of N,N-diethyl-4-(3-fluorophenyl-piperidin-4-ylidene-methyl)-benzamide hydrochloride salt
09/19/2007CN101036648A Liquid formulations for dermal application in treatment of parasitic insects in animals
09/19/2007CN100338057C Halogenated nitrobutadienes for controlling animal pests
09/19/2007CN100338045C Solidifiable composition containing thiazole functional group
09/19/2007CN100338044C HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
09/19/2007CN100338042C Triazole derivatives as cyclooxygenase (COX) inhibitors
09/19/2007CN100338036C Substd. indolinones having inhibiting effect on kinases and cycline/CDK complexes
09/19/2007CN100337626C Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
09/19/2007CN100337545C Liquid formulations for dernal application in treatment of parasitic insects in animals
09/18/2007US7271270 High affinity small molecule C5a receptor modulators
09/18/2007US7271265 Cyanine compounds and their application as quenching compounds
09/18/2007US7271195 Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
09/18/2007US7271184 For controlling parasites on warm-blooded animals; veterinary medicine
09/18/2007US7271181 Inhibitors of p38
09/18/2007US7271179 Inhibitors of JAK protein kinase
09/18/2007US7271168 Piperazine derivatives having SST1 antagonistic activity
09/18/2007CA2416229C Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
09/18/2007CA2274177C Process for the preparation of thiazole derivatives
09/13/2007WO2007104034A2 Glucokinase activators
09/13/2007WO2007103670A2 Novel compounds that are useful for improving pharmacokinetics
09/13/2007WO2007103554A1 Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
09/13/2007WO2007102771A1 Phenethanolamine derivatives as beta2 adrenoreceptor agonists
09/13/2007WO2007102515A1 Phenylthiazole derivative
09/13/2007WO2007101531A1 Use of adenosine a1 and/or dual a1/a2b agonists for production of medicaments for treating diseases
09/13/2007WO2007101347A1 Bir domain binding compounds
09/13/2007WO2007087488A3 Indole sulfonamide modulators of progesterone receptors
09/13/2007WO2007082808A3 Thiazoles as 11 beta-hsd1 inhibitors
09/13/2007WO2007079199A3 Substituted bis-amide metalloprotease inhibitors
09/13/2007WO2007060140A3 Inhibitors of diacyglycerol acyltransferase (dgat)
09/13/2007US20070213387 Such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; protein kinase C inhibitors; for treatment of diabetes
09/13/2007US20070213386 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-[2-[3-(dimethylamino)-2-hydroxypropoxy]phenyl]-4-(1-ethenyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione, used for treating diabetes, dementias such as Alzheimer's disease and bipolar disorders
09/13/2007US20070213375 Triazole derivatives useful as Axl inhibitors
09/13/2007US20070213372 Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands
09/13/2007US20070213367 Substituted 3-cyanoquinolines as MEK inhibitors
09/13/2007US20070213346 Substituted 4-Alkyl-And 4-Alkanoyl-Piperidine Derivatives And Their Use As Neurokinin Antagonists
09/13/2007US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
09/13/2007US20070213330 Anticancer agents; antiproliferative agents
09/13/2007US20070213325 Multi-cyclic compound and method of use
09/13/2007US20070213323 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
09/13/2007US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/13/2007US20070213315 Modulators of muscarinic receptors
09/13/2007US20070213301 Substituted Aminothiazole Derivatives With Anti-HCV Activity
09/13/2007CA2645072A1 Substituted aminothiazole derivatives with anti-hcv activity